n-acetylcysteine and glutathione The Central Nervous System Modulatory Activities of N-Acetylcysteine: A Synthesis of Two Decades of Evidence N.A.C. N-Acetylcysteine Glutathione Precursor

Glutathione levels are also found to be decreased in central nervous system disorders (such as Alzheimer disease and Parkinson disease), autism, cardiovascular system disorders (atherosclerosis), peripheral vascular disorders, diabetes and its complications, liver disease, acquired immunodeficiency syndrome/human immunodeficiency virus, and chronic obstructive pulmonary diseases

H., Solari F

In this review, we have documented the crucial role of HBOT as an adjuvant treatment, particularly in encouraging tissue regeneration, as well as its probable implications on the consequences of cellular ageing

J Cell Biochem 113:19661976